由于已注销的购股权将被视为已动用，以计算该计划项下的计划授权上限及服务提供者分项限额，故计 划授权上限及服务提供者分项限额项下可供未来授出的股份数目分别维持约726.15万股及478.99万股。 中国卫生集团(00673)发布公告，于2026年2月13日，根据该计划的条款，董事会透过向承授人发出书面 通知宣布该等购股权据此注销，以行使酌情权悉数注销于2026年2月2日授出且任何承授人未有效行使的 4063.8万份购股权。 ...

Core Viewpoint - Huiyuan Tongchuang Technology (01116) announced the cancellation of 174.8 million unvested and unexercised stock options granted to Ling Li, effective September 24, 2025, due to unmet vesting conditions as per the advisor agreement and stock option plan [1] Group 1 - The board of directors decided to cancel the stock options to ensure compliance and proper management of the plan [1] - The cancellation is deemed to be in the best interest of the company and its shareholders [1] - Independent legal advice was considered in making the decision [1]